Nightstar

Developer of gene therapies for retinal diseases

placeLondon, England, United Kingdom calendar_todayFounded 2013 groups15 employees language nightstartx.com

Registered entities

Social engagement

Social engagement: 1.3M social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include New Enterprise Associates; 2 have since exited.

Investor typeCountShare
Venture capital450%
Accelerator & incubator225%
Other / undisclosed225%

Recent activity

29 Jun 2026
Event
Alzheimer's Association® International Conference (AAIC)
26 Jun 2026
Event
European Academy of Neurology (EAN) Congress
25 Jun 2026
Event
Cure SMA 2026 Annual SMA Conference
Coming soon